What is the share price of Brabourne Enterprises Ltd. (Amalgamated) (BRABOURNE)?

Company share prices are keep on changing according to the market conditions. The current trading price of Brabourne Enterprises Ltd. (Amalgamated) (BRABOURNE) on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Brabourne Enterprises . (Amalgamated)?

The latest standalone P/E ratio of Brabourne Enterprises . (Amalgamated) as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Brabourne Enterprises Ltd. (Amalgamated) (BRABOURNE)?

The latest standalone P/B ratio of Brabourne Enterprises Ltd. (Amalgamated) (BRABOURNE) as of 01-Jan-1970 is 0.23.

What is the 52-week high and low of Brabourne Enterprises Ltd. (Amalgamated) (BRABOURNE)?

The 52-week high of Brabourne Enterprises Ltd. (Amalgamated) (BRABOURNE) is Rs. 10.40 and the 52-week low is Rs. 9.60.

Brabourne Enterprises Ltd. (Amalgamated) (BRABOURNE) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Brabourne Enterprises Ltd. (Amalgamated) (BRABOURNE)
Brand: Brabourne Enterprises . (Amalgamated)

Brabourne Enterprises Ltd. (Amalgamated) (BRABOURNE)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 500384 NSE: BRABOURNE Pharmaceuticals & Drugs | Small Cap | Brabourne Enter Share Price

Brabourne Enterprises Ltd. (Amalgamated) (BRABOURNE)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 500384 NSE: BRABOURNE Pharmaceuticals & Drugs | Small Cap | Brabourne Enter Share Price

Key Metrics

Valuation Multiples

Market Cap

₹15 Cr.

Current Price

₹0

52-Week Low / High

₹10 / 10

TTM EPS

₹-0.1

TTM Sales

₹0 Cr.

Book Value per Share

₹43.3

P/E Ratio

0.00

Industry PE

49.2

Price to Book (P/B)

0.23

Price to Sales (P/S)

7292.19

EV/EBITDA

-195.33

Dividend Yield

NAN%

Profitability Efficiency

Return on Equity (ROE)

-39.22%

Return on Capital Employed (ROCE)

-22.83%

Return on Assets (ROA)

-21.67%

Operating Profit Margin

Net Profit Margin

Gross Profit Margin

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Steady versus 3-year growth rate

-100%

Operating Profit Growth (1 Year)

-100.39%

Net Profit Growth (1 Year)

-466.75%

Asset Quality

Promoter Holding

43.71%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹48 Cr.

Equity

₹14.4 Cr.

Face Value

₹10

All Time Low / High

₹4.55 / 206.95

Brabourne Enterprises . (Amalgamated) stock performance

Key Ratios

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'98	Mar'99	Mar'00	Sep'01	Mar'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08	TTM
ROCE % ⓘ	11.1%	14.8%	14.2%	15.5%	-4.4%	5.5%	7.1%	21.8%	11.9%	-22.8%	-
Growth Parameters ⓘ
Sales ⓘ	186	213	181	185	107	119	124	145	121	0	0
Sales YoY Gr.	-	14.7%	-15.1%	2.1%	-42.2%	11.8%	4.1%	16.6%	-16.5%	-100%	-
Adj EPS ⓘ	4.9	8.6	7.4	3.2	-8.2	-5.3	-3.4	13.8	5.9	-7.8	-0.1
YoY Gr.	-	76.4%	-14.3%	-56.1%	-354.5%	NA	NA	NA	-57.2%	-232.4%	-
BVPS (₹) ⓘ	83.2	81.2	78.7	52.8	32.9	45.9	32.8	59.7	63.8	43.4	43.3
Adj Net Profit ⓘ	5.3	9.4	9.1	4	-10.2	-6.6	-4.2	19.8	8.5	-11.2	-0
Cash Flow from Ops. ⓘ	-7.5	-11.4	0.2	20.4	39.6	32.7	22.5	44.4	15.3	0.1	-
Debt/CF from Ops. ⓘ	-12.1	-9.7	570.8	5.4	2.5	3.9	5.3	2.1	5.5	0	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	-100%	-100%	-100%	-100%
Adj EPS ⓘ	-205.4%	NA	NA	-232.4%
BVPSⓘ	-7%	5.7%	9.8%	-31.9%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

	Mar'98	Mar'99	Mar'00	Sep'01	Mar'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08	TTM
Return on Equity % ⓘ	5.8	10.2	9.4	5.9	-18	-10.6	-8.5	30.9	9.4	-14.5	-0.1
Op. Profit Mgn % ⓘ	8.1	11.8	13.1	12.8	2.7	12.2	9.3	27.4	19.4	0	NAN
Net Profit Mgn % ⓘ	2.9	4.4	5.1	2.2	-9.6	-5.5	-3.4	13.6	7	0	-INF
Debt to Equity ⓘ	1	1.2	1.4	1.7	2.4	2.2	2.9	1.1	0.9	0	-
Working Cap Days ⓘ	0	190	274	210	361	418	381	328	391	0	0
Cash Conv. Cycle ⓘ	0	71	102	67	77	22	4	-42	-18	0	0

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'98	Mar'99	Mar'00	Sep'01	Mar'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08
Sales	186	213.29	181	277.23	160.30	119.48	124.37	145.04	121.13	0
Operating Expenses ⓘ +	172.65	189.43	157.75	242.36	157.01	107.56	113.49	105.51	97.97	0.09
Manufacturing Costs	13.31	13.49	15.49	26.51	16.34	17.45	20.42	10.42	12.84	0
Material Costs	109.10	116.18	79.64	125.88	60.15	42.85	43.03	43.10	41.93	0
Employee Cost	15.87	19.11	20.49	30.95	26.92	17.80	19.56	19.38	20.57	0.01
Other Costs ⓘ	34.37	40.64	42.13	59.01	53.59	29.46	30.48	32.62	22.63	0.08
Operating Profit ⓘ	13.35	23.86	23.25	34.87	3.28	11.92	10.88	39.53	23.15	-0.09
Operating Profit Margin (%)	7.2%	11.2%	12.8%	12.6%	2.0%	10.0%	8.7%	27.3%	19.1%	-
Other Income ⓘ +	12.28	10.58	14.64	14.23	7.98	5.93	6.02	3.27	2.87	0
Exceptional Items ⓘ	0	0	0	0	-15.27	0	0	0	0	-27.17
Interest ⓘ	14.98	17.37	19.75	32.44	28.57	19.59	16.88	14.86	11.34	0
Depreciation ⓘ	5.54	6.29	7.03	10.40	6.42	7.12	4.69	5.59	4.76	0
Profit Before Tax ⓘ	5.10	10.78	11.11	6.25	-39.01	-8.86	-4.67	22.36	9.92	-27.26
Tax ⓘ	0.50	2.10	2.18	0.65	-12.30	-2.08	0	2.67	1.68	2.97
Profit After Tax	4.60	8.68	8.93	5.60	-26.70	-6.78	-4.67	19.69	8.24	-30.22
PAT Margin (%)	2.5%	4.1%	4.9%	2.0%	-16.7%	-5.7%	-3.8%	13.6%	6.8%	-
Adjusted EPS (₹)	4.2	8.0	7.2	4.5	-21.5	-5.5	-3.8	13.7	5.7	-21.0
Dividend Payout Ratio (%)	52.20%	30.20%	33.40%	53.20%	0%	0%	0%	18.30%	26.20%	0%

Valuation of Brabourne Enter - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'98	Mar'99	Mar'00	Sep'01	Mar'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08
Equity and Liabilities
Shareholders Fund +	91.59	92.39	101.91	104.23	66.11	57.93	41.28	85.99	91.71	62.44
Share Capital ⓘ	10.93	10.93	12.45	12.45	12.45	12.45	12.45	14.39	14.39	14.39
Reserves ⓘ	80.66	81.46	89.47	91.78	53.66	45.48	28.83	71.60	77.32	48.05
Debt +	90.72	109.84	139.62	164.05	148.42	125.83	119.23	94.18	83.64	0
Long Term Debt	90.72	109.84	139.62	164.05	148.42	125.83	119.23	94.18	83.64	0
Short Term Debt	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	24.69	27.81	29.94	39	32.47	33.71	37.50	37.94	30.93	0.01
Others Liabilities ⓘ	15.32	15.32	18.02	16.69	6.31	6.09	8.88	18.20	9.25	0.89
Total Liabilities ⓘ	222.32	245.37	289.49	323.97	253.31	223.56	206.90	236.30	215.53	63.33
Fixed Assets
Net Fixed Assets ⓘ +	70.96	75.40	73.16	76.28	50.11	45.74	42.26	42.10	38.59	0.77
Gross Block	93.49	103.99	108.47	121.79	79.74	85.78	86.95	92.38	93.27	1.20
Accumulated Depreciation	22.54	28.60	35.31	45.51	29.63	40.04	44.69	50.27	54.68	0.43
CWIP ⓘ	4.01	1.62	0.24	11.89	2.09	1.80	1.71	0.13	11.97	0
Investments ⓘ	27.97	26.94	20.52	30.04	35.39	32.09	32.15	36.84	32.78	53
Inventories	38.96	35.88	39.58	41.20	24.72	25.50	27.79	23.34	19.27	0
Trade Receivables	35.25	55.47	64.83	71.84	34.82	24.91	22.51	25.43	24.42	0
Cash Equivalents	3.24	2.89	19.87	4.30	1.70	1.03	0.64	27.17	8.09	0.13
Others Assets ⓘ	41.94	47.17	71.29	88.43	104.47	92.50	79.85	81.28	80.41	9.43
Total Assets ⓘ	222.32	245.37	289.49	323.97	253.31	223.56	206.90	236.30	215.53	63.33

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'98	Mar'99	Mar'00	Sep'01	Mar'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08
Cash Flow From Operating Activity ⓘ +	-7.51	-11.35	0.24	30.62	59.39	32.66	22.49	44.38	15.33	0.12
PBT ⓘ	5.10	10.78	11.11	6.25	-20.90	-8.86	-4.67	22.36	9.92	-27.26
Adjustment ⓘ	18.16	17.74	25.43	43.22	35.91	27.39	22.48	22.65	15.09	27.17
Changes in Working Capital ⓘ	-13.7	-16.9	-33.03	-17.75	47.23	13.53	8.72	4.46	-9.44	0.26
Tax Paid ⓘ	-2.14	-5.62	0	-1.11	0	0.60	-4.04	-5.09	-0.24	-0.05
Cash Flow From Investing Activity ⓘ +	-6.45	-4.72	6.08	-36.08	-12.28	9.20	1.35	-9.22	-8.21	-0
Capex	-11.27	-8.87	-3.98	-24.10	25.55	1.95	-1.33	-4.52	-13.23	0
Net Investments	0	1.03	6.42	-9.52	-10.48	1.07	-0.05	-4.72	4.07	0
Others ⓘ	4.82	3.12	3.64	-2.46	-27.36	6.18	2.73	0.02	0.96	-0
Cash Flow From Financing Activity ⓘ +	14.48	15.73	12.19	-10.10	-49.75	-41.62	-24.21	-8.54	-26.21	-2.52
Net Proceeds from Shares ⓘ	0.43	0.19	3.60	0	0	0	0	30.65	0	0
Net Proceeds from Borrowing ⓘ	15.35	2.88	6.19	6.99	17.05	-16.38	-13.61	-24.56	-19.20	0
Interest Paid ⓘ	0	0	-19.53	-31.37	-28.88	-20.59	-16.22	-16.01	-12.95	0
Dividend Paid ⓘ	-2.31	-2.38	-2.69	-2.87	-3.02	0	0	0	-3.59	-2.16
Others ⓘ	1	15.05	24.61	17.16	-34.90	-4.64	5.62	1.38	9.53	-0.37
Net Cash Flow ⓘ	0.51	-0.33	18.51	-15.56	-2.64	0.24	-0.37	26.62	-19.09	-2.40

Financial Ratio

PARTICULARS	Mar'98	Mar'99	Mar'00	Sep'01	Mar'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08
Ratios
ROE (%)	5.07	9.68	9.58	5.71	-33.43	-11.46	-9.54	31.11	9.29	-39.22
ROCE (%)	11.06	14.81	14.15	15.48	-4.42	5.46	7.12	21.83	11.9	-22.83
Asset Turnover Ratio	0.95	1.03	0.76	1.04	0.62	0.55	0.63	0.72	0.58	0
PAT to CFO Conversion(x)	-1.63	-1.31	0.03	5.47	N/A	N/A	N/A	2.25	1.86	N/A
Working Capital Days
Receivable Days	60.80	68.80	107.80	78.30	108.60	82.80	63.70	55.20	69.80	0
Inventory Days	67.30	56.80	67.60	46.30	67.10	69.60	71.50	58.90	59.70	0
Payable Days	82.60	76.80	122	94.70	204.50	273.90	293.70	306.90	287.70	0

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Brabourne Enterprises Ltd. (Amalgamated) FAQs

The current trading price of Brabourne Enter on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Brabourne Enter stood at ₹14.58 Cr

The latest P/E ratio of Brabourne Enter as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Brabourne Enter as of 31-Dec-1969 is 0.23.

The 52-week high of Brabourne Enter is ₹10.40 and the 52-week low is ₹9.60.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Brabourne Enter is ₹0.00 ( Cr.) .

Data is not available for this company.

No data found

About Brabourne Enterprises Ltd. (Amalgamated)

Brabourne Enterprises Ltd the demerged arm of RPG life was incorporated on May 12, 1967. The entire pharmaceuticals business of the Company has been sold to RPG Life Sciences Ltd. (formerly RPG Pharmaceuticals Ltd.) with effect from April 2, 2007 on going concern basis along with all assets and liabilities pertaining to the said business, at consideration of Rs. 46 crore. Thus, the results and revenue of the pharmaceutical business from April 2, 2007 has become revenue and results of RPG Pharmaceuticals Ltd. The unaudited financial results of the company for 9 months ended December 31, 2007, which pertains to the pharmaceutical business. The Group operates in two segments, namely, Pharmaceuticals and Investments and lending.

The entire Investments held by the company (excluding US 64 bonds) stands sold to Instant Holdings Ltd effective from April 1, 2007, at a consideration of Rs 53 crore. Instant Trading and Investment Company Ltd is a wholly owned subsidiary of RPG Life Sciences Ltd. RPG Pharmaceuticals Ltd and Instant Holdings Ltd were incorporated on March 29, 2007 to participate in the Scheme of Arrangement.

The assets and liabilities of the Instant Trading and Investment Company Ltd were transferred to Instant Holdings Ltd and Instant Trading and Investment Company Ltd stands dissolved without winding up. Then only the company changed its name to â€˜Brabourne Enterprises Ltdâ€™ and RPG Pharmaceuticals Ltd changed its name to â€˜RPG Life Sciences Ltdâ€™.

The plants of Brabourne Enterprises are located at Gujarat and Maharashtra.

Business area of the company:

The Company is engaged in manufacture of active pharmaceutical ingredients, both synthetic and fermentation, contract API and formulation development business with a niche product portfolio, both in chronic and acute therapy areas.

Brabourne Enterprises Ltd. (Amalgamated) (BRABOURNE)

Brabourne Enterprises Ltd. (Amalgamated) (BRABOURNE)

Brabourne Enterprises . (Amalgamated) stock performance

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Brabourne Enter - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Brabourne Enterprises Ltd. (Amalgamated) FAQs

About Brabourne Enterprises Ltd. (Amalgamated)

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Brabourne Enterprises Ltd. (Amalgamated) (BRABOURNE)

Brabourne Enterprises Ltd. (Amalgamated) (BRABOURNE)

Brabourne Enterprises . (Amalgamated) stock performance

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Brabourne Enter - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Brabourne Enterprises Ltd. (Amalgamated) FAQs

What is the share price of Brabourne Enter?

What is the market cap of Brabourne Enter?

What is the P/E ratio of Brabourne Enter?

What is the P/B ratio of Brabourne Enter?

What is the 52-week high and low of Brabourne Enter?

What is the TTM revenue of Brabourne Enter?

Is a good quality company?

Is undervalued or overvalued?

Is a good buy now?

About Brabourne Enterprises Ltd. (Amalgamated)

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.